Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones
dc.contributor.author | Olawode, Emmanuel O. | |
dc.contributor.author | Tandlich, Roman | |
dc.contributor.author | Prinsloo, Earl | |
dc.contributor.author | Isaacs, Michelle | |
dc.contributor.author | Hoppe, Heinrich | |
dc.contributor.author | Seldon, Ronnett | |
dc.contributor.author | Warner, Digby F. | |
dc.contributor.author | Steenkamp, Vanessa | |
dc.contributor.author | Kaye, Perry T. | |
dc.date.accessioned | 2019-08-28T07:57:13Z | |
dc.date.issued | 2019-07 | |
dc.description.abstract | A series of novel, substituted 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones have been prepared and shown to exhibit promising concentration-dependent activity against human SH-SY5Y cells, Plasmodium falciparum, Mycobacterium tuberculosis and P. aeruginosa. Substituent effects on observed bioactivity have been explored; the para-fluorophenyl derivative 3d exhibited activity across the range of the bioassays employed, indicating the potential of the 2-chloro-3-[(4-arylthiazol-2-yl)amino]-1,4-naphthoquinone scaffold in the development of novel, broad spectrum therapeutics. | en_ZA |
dc.description.department | Pharmacology | en_ZA |
dc.description.embargo | 2020-07-01 | |
dc.description.librarian | hj2019 | en_ZA |
dc.description.sponsorship | Rhodes University for bursary support (to E.O.O.) and the South African Medical Research Council (SAMRC) and Rhodes University for research funding. | en_ZA |
dc.description.uri | http://www.elsevier.com/ locate/bmcl | en_ZA |
dc.identifier.citation | Olawode, E.O., Tandlich, R., Prinsloo, E. et al. 2019, 'Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones', Bioorganic and Medicinal Chemistry Letters, vol. 29, no. 13, pp. 1572-1575. | en_ZA |
dc.identifier.issn | 0960-894X (print) | |
dc.identifier.issn | 1464-3405 (online) | |
dc.identifier.other | 10.1016/j.bmcl.2019.05.001 | |
dc.identifier.uri | http://hdl.handle.net/2263/71217 | |
dc.language.iso | en | en_ZA |
dc.publisher | Elsevier | en_ZA |
dc.rights | © 2019 Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Bioorganic and Medicinal Chemistry Letters. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Bioorganic and Medicinal Chemistry Letters, vol. 29, no. 13, pp. 1572-1575, 2019. doi : 10.1016/j.bmcl.2019.05.001. | en_ZA |
dc.subject | 2-Chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones | en_ZA |
dc.subject | Anti-malarial | en_ZA |
dc.subject | Anti-bacterial | en_ZA |
dc.subject | Anti-tuberculosis | en_ZA |
dc.subject | Cytotoxicity | en_ZA |
dc.subject | HeLa cells | en_ZA |
dc.title | Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones | en_ZA |
dc.type | Postprint Article | en_ZA |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description: